Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Olive Oil Polyphenols and Cardiovascular Health Biomarkers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04149288
Recruitment Status : Not yet recruiting
First Posted : November 4, 2019
Last Update Posted : February 10, 2020
Sponsor:
Information provided by (Responsible Party):
Francene Steinberg, University of California, Davis

Brief Summary:
The purpose of this research is to investigate whether consuming two different kinds of olive oil will change risk factors related to cardiovascular disease, including levels of good and bad cholesterol, levels of inflammation, and levels of gene expression.

Condition or disease Intervention/treatment Phase
Healthy Normal Weight Overweight Obese Dietary Supplement: High-polyphenol olive oil Dietary Supplement: Low-polyphenol olive oil Not Applicable

Detailed Description:

The purpose of this research is to investigate whether consuming two different kinds of olive oil will change risk factors related to cardiovascular disease, including levels of good and bad cholesterol, levels of inflammation, and levels of gene expression. Healthy individuals aged 20-45 with a BMI over 20 kg/m2 are eligible to participate. The study involves 5 visits (1 initial screening and 4 study visits) and will last about 8 weeks. There is a 2-week run-in period before starting the study, followed by two diet intervention periods each lasting two weeks, separated by a two-week washout period.

Participation in this study will involve an initial two-week run in period to become accustomed to the study diet. After this two week period, participants will be randomly selected to start either a high-polyphenol olive oil (extra virgin olive oil) or a low-polyphenol olive oil (refined olive oil); participants will consume the other oil during the second dietary intervention period lasting 2 weeks. During each phase of the study, participants will be asked to come to the UC Davis campus after a 10-12 hour overnight fast. At each visit, body measurements will be taken, a serving of olive oil and bread will be eaten, and three urine and blood samples will be collected over the course of 4 hours. Each study visit will involve three blood draws by a trained nurse or phlebotomist.

During the 8 weeks of the study, all olive products such as olives, olive oil, and olive containing products will need to be avoided. The study will provide olive oil to be eaten at home for each intervention phase. Additionally, the investigators will ask that nuts and high-polyphenol foods (mostly fruits and vegetables) be avoided in the diet. Detailed food diaries will be filled out and brought to study visits.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 44 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Basic Science
Official Title: Olive Oil Polyphenols and Cardiovascular Health Biomarkers
Estimated Study Start Date : March 2020
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : October 2021

Resource links provided by the National Library of Medicine

Drug Information available for: Olive oil

Arm Intervention/treatment
Active Comparator: High-polyphenol olive oil
Participants will consume 40 mL of high-polyphenol olive oil each day at home for 2 weeks.
Dietary Supplement: High-polyphenol olive oil
High-polyphenol olive oil will be provided to study participants to consume at home. Participants will be asked to consume 40 mL each day for 2 weeks.

Active Comparator: Low-polyphenol olive oil
Participants will consume 40 mL of low-polyphenol olive oil each day at home for 2 weeks.
Dietary Supplement: Low-polyphenol olive oil
Low-polyphenol olive oil will be provided to study participants to consume at home. Participants will be asked to consume 40 mL each day for 2 weeks.




Primary Outcome Measures :
  1. Assessing the influence of olive oil polyphenols on cholesterol efflux [ Time Frame: Through study completion, an average of 8 weeks ]
    Cholesterol efflux will be measured by assessing changes in reverse cholesterol transport rate in separated serum at each study time point (baseline, 2 hour, 4 hour) using a commercially available assay kit at each of the 4 study visits.

  2. Assessing the influence of olive oil polyphenols on cholesterol ester transfer protein activity (CETP) [ Time Frame: Through study completion, an average of 8 weeks ]
    Changes in CETP activity will be measured at each study time point (baseline, 2 hour, 4 hour) in plasma at each of the 4 study visits. The isolated plasma will be co-incubated with donor and acceptor molecules using a commercially available assay kit.

  3. Assessing the influence of olive oil polyphenols on circulating oxidized LDL [ Time Frame: Through study completion, an average of 8 weeks ]
    Measure for changes in circulating levels of oxidized LDL in separated plasma at each study time point (baseline, 2 hour, 4 hour) using a commercially available ELISA kit; measured in units of U/L at each of the 4 study visits.

  4. Assessing the influence of olive oil polyphenols on blood lipid measurements [ Time Frame: Through study completion, an average of 8 weeks ]
    Measure for changes in the levels of HDL and LDL in separated plasma; measured in units of mg/dL. Blood will be assessed for the fasting (baseline) sample only at each of the 4 study visits.

  5. Assessing the influence of olive oil polyphenols on paraoxinase-1 (PON-1) activity [ Time Frame: Through study completion, an average of 8 weeks ]
    Measure for changes in PON-1 activity in separated plasma at each study time point (baseline, 2 hour, 4 hour) at each of the 4 study visits. Activity will be calculated based on linear rates of hydrolysis of phenyl acetate to phenol.

  6. Assessing the influence of olive oil polyphenols on peripheral blood mononuclear cells (PBMC) using ex vivo stimulation assays [ Time Frame: Through study completion, an average of 8 weeks ]
    Measurement of changes in PBMC derived cytokines as a marker of inflammation at each study time point (baseline, 2 hour, 4 hour) at each of the 4 study visits. Assessment will be based on an increase or decrease in concentration in pg/ml.


Secondary Outcome Measures :
  1. Assessing the influence of olive oil polyphenols on gene expression in mirco RNA in PBMCs [ Time Frame: Through study completion, an average of 8 weeks ]
    Measure level of gene expression in micro RNA from PBMCs at each study time point (baseline, 2 hour, 4 ) at each of the 4 study visits. Assessment will be based on fold change between study arms.


Other Outcome Measures:
  1. Food record anaylsis [ Time Frame: Through study completion, an average of 8 weeks ]
    Use a computer program to check for study dietary requirements. Subjects are to avoid olives and olive containing products during study protocol periods. This will be done using a subject self-recorded 3-day food record submitted to study personnel.

  2. Anthropometric measurements [ Time Frame: Through study completion, an average of 8 weeks ]
    Measure waist (cm) and hip circumference (cm) before the start of drawing blood on study day protocols.

  3. Measure for changes in weight [ Time Frame: Through study completion, an average of 8 weeks ]
    Measure weight (kg) before the start of drawing blood on study day protocols.

  4. Measure for changes in blood pressure [ Time Frame: Through study completion, an average of 8 weeks ]
    Measure blood pressure (mmHg) before the start of drawing blood on study day protocols.

  5. Assessing the influence of olive oil polyphenols on circulating cytokines [ Time Frame: Through study completion, an average of 8 weeks ]
    Measure circulating cytokines in separated plasma at each study time point (baseline, 2 hour, 4 hour) at each of the 4 study visits. Commercially available ELISA kits will be used: TNF-a, IL-6, IL-1B, MCP-1, and ET-1.

  6. Assessing the influence of olive oil polyphenols on urine metabolites [ Time Frame: Through study completion, an average of 8 weeks ]
    Metabolomics will be performed on urine to assess for study compliance of consumption of the polyphenol containing olive oil versus the low-polyohenol containing olive oil at each of the 4 study visits.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Generally healthy male and female subjects within the range of 20-45 years of age and BMI range of 18.5-29.9 kg/m2 for the healthy weight/overwight group and ≥ 30 kg/m2 for the obese group will be recruited.

Exclusion Criteria:

  • Adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant or lactating women, women planning to become pregnant in the next two months and prisoners will be specifically excluded
  • Documented chronic diseases including diabetes, thyroid disease, kidney disease, metabolic syndrome, active cancer, previous cardiovascular events, history of gastric bypass or other GI issues related to fat absorption
  • History of dyslipidemia or abnormal blood glucose levels (total cholesterol >240 mg/dL, elevated fasting blood glucose levels >125 mg/dL)
  • Allergy to olives, inability to tolerate gluten or multiple allergies/intolerances that would significantly limit food intake
  • Smoker or living with a smoker, illicit drug use, consuming >1 alcoholic drink/day, vaporizer and/or electronic cigarette use
  • Extreme dietary or exercise patterns
  • Recent weight fluctuations (>10% in the last 6 months)
  • Taking prescription lipid medications or supplements that may affect lipoprotein metabolism, >1 g of fish oil/day, antioxidant supplements, CBD oil
  • Taking exogenous hormones (e.g. hormonal birth control)
  • Poor venous access
  • Unwillingness to comply with study protocol

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04149288


Contacts
Layout table for location contacts
Contact: Francene M Steinberg, PhD, RD (530) 752-0160 fmsteinberg@ucdavis.edu
Contact: Jody Randolph, MS (530) 752-7620 jmrandolph@ucdavis.edu

Locations
Layout table for location information
United States, California
Ragle Human Nutrition Center
Davis, California, United States, 95616
Sponsors and Collaborators
University of California, Davis

Layout table for additonal information
Responsible Party: Francene Steinberg, Professor of Nutrition; Director Didactic Program in Dietetics; Chair Department of Nutrition, University of California, Davis
ClinicalTrials.gov Identifier: NCT04149288    
Other Study ID Numbers: 1484263
First Posted: November 4, 2019    Key Record Dates
Last Update Posted: February 10, 2020
Last Verified: February 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Overweight
Body Weight
Signs and Symptoms